Alabama Governor Kay Ivey dropped the most accurate and succinct campaign ad to date. She’s starting the 2022 election off with fire.
Alabama Governor Kay Ivey shared what she has done for Alabama and what she will continue to do – protect the election process from being stolen like President Trump’s election was stolen in 2020.
The fake news, Big Tech and blue state liberals stole the election from President Trump.”
“But here in Alabama, we are making sure that never happens,” she continues. “We have not, and will not, send absentee ballots to everyone and their brother. We banned corrupt curbside voting, and our results will always be audited. I’m Kay Ivey. The Left is probably offended. So be it. As long as I’m governor, we’re going to protect your vote.”
Pfizer hired 600 employees with a plan to hire a total of 1,800 employees when side effects from its COVID vaccine started showing up. The employees were hired to address the flood in adverse effects reporting.
Posted by Jim Holt for The Gateway Pundit April 10, 2022 at 4:00pm
Pfizer hired 600 employees in the months after its COVID-19 vaccine was authorized in the United States due to the “large increase” of reports of side effects linked to the vaccine, according to a document prepared by the company.
Pfizer has “taken a multiple actions to help alleviate the large increase of adverse event reports,” according to the document. “This includes significant technology enhancements, and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues.”
At the time when the document—from the first quarter of 2021—was sent to the U.S. Food and Drug Administration (FDA), Pfizer had onboarded about 600 extra full-time workers to deal with the jump.
“More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021,” Pfizer said.
Pfizer tried to hide the information
Finally got the unredacted version of this FoIA’d document. Three months after the release of the vaccine Pfizer had to hire 600 additional full-time employees, with a plan to hire 1800 total, just to process the flood of adverse events reported. pic.twitter.com/5emJ0s9djl
The analysis of adverse event reports was previously disclosed to the health transparency group, but certain portions were redacted (pdf), including the number of workers Pfizer onboarded to deal with the jump in adverse event reports.
“We asked that the redactions on page 6 of this report be lifted and the FDA agreed without providing an explanation,” Aaron Siri, a lawyer representing the plaintiffs, told The Epoch Times in an email.
After the document was produced, the FDA determined that the three redactions on that page “could be lifted,” an FDA spokesperson told The Epoch Times via email.
The redactions had been made under (b) (4) of the Freedom of Information Act, which lets agencies “withhold trade secrets and commercial or financial information obtained from a person which is privileged or confidential.”
The unredacted version of the document also now shows that approximately 126 million doses of Pfizer were shipped around the world since the company received the first clearance, from U.S. regulators, on Dec. 1, 2020. The shipments took place through Feb. 28, 2021.
It was unclear how many of those doses had been administered as of that date.
As TGP reported previously, after the courts ordered Pfizer to release data on its COVID vaccine, documents showed over 1,200 vaccine deaths in the first 90 days after taking the vaccine.
TGP has reported many additional reports of deaths or injuries caused by the Pfizer vaccine. The information to date does not look good for the Pfizer vaccine.
FILE - This 2018 portrait released by the U.S. Department of Justice shows Connecticut's U.S. Attorney John Durham. Durham, the federal prosecutor tapped to investigate the origins of the Russia investigation, has been presenting evidence before a grand jury as part of his probe, a person familiar with the matter said Friday, Aug. 13, 2021. (U.S. Department of Justice via AP, File)
Visits: 31
Crossfire Hurricane
By Zachary Stieber for the Epoch Times April 7, 2022
Special counsel John Durham’s team on April 6 asked a federal judge to force Hillary Clinton’s presidential campaign and two other parties to hand over documents they claim are protected by attorney–client privilege.
The campaign, the Democratic National Committee (DNC), and research and intelligence firm Fusion GPS appear to be withholding documents that aren’t actually protected by the privilege, Durham’s team said in the filing, entered in the case against ex-Clinton lawyer Michael Sussmann.
Of the withheld materials, almost all “appear to lack any connection to actual or expected litigation or the provision of legal advice,” prosecutors told U.S. District Judge Christopher Cooper, an Obama appointee who is overseeing the case.
In fact, of the 1,455 documents being withheld by Fusion GPS, only 18 emails and attachments are said to involve an attorney.
The Clinton campaign, the DNC, and Fusion didn’t respond to requests for comment.
The documents in question are being sought for the upcoming trial of Sussmann, who was charged with lying to the FBI for going to a bureau lawyer in 2016 and falsely stating he didn’t hand over unsubstantiated claims about then-candidate Donald Trump on behalf of a client.
The claims were compiled with funding from the campaign and the DNC by former British spy Christopher Steele and Fusion GPS, which was founded by former reporters.
Sussmann and his lawyers have been pressing the judge to dismiss the case prior to trial, arguing that the lie about not bringing the information on behalf of a client wasn’t material to the information itself.
Attorney–client privilege protects many communications between a client and their lawyer. Disclosure to third parties usually undercuts privilege claims.
In the new filing, Durham’s team pointed out that Fusion GPS co-founders Glenn Simpson and Peter Fritsch penned a book published in 2019, which means even if a valid privilege did once exist, it might have since been waived.
Prosecutors also noted that Fusion GPS operatives regularly communicated with reporters about their work, resulting in several stories before the 2020 election and a spate of others after voters hit the polls.
Further, the Clinton campaign (HFA) and the DNC have claimed privilege over communications sent between Rodney Joffe, whom Sussmann was also representing at the time, and a Fusion operative, “despite the fact that no one from either the DNC or HFA is copied on certain of these communications,” prosecutors said.
The government subpoenaed information from the parties in 2021.
Many if not most of the actions taken by Fusion GPS employees “do not appear to have been a necessary part of, or even related to” Perkins Coie’s legal advice to the campaign and the DNC, Durham’s team said.
Prosecutors want to examine the communications in a private, in-camera setting “in order to resolve these issues and ensure that only legitimately privileged and/or attorney work product-protected communications and testimony be withheld from the otherwise admissible evidence and testimony that is presented to the jury at trial.”
By:Jenna Schauer, MD Sujatha Buddhe, MD, MS Avanti Gulhane, MD, DNB, FSCMR Sathish Mallenahalli Chikkabyrappa, MD Yuk Law, MD Michael A. Portman, MD et al for The Journal of Pediatrics
Myopericarditis, , has emerged as an important adverse event following COVID-19 mRNA vaccination, particularly in adolescents [1]
Patients typically exhibit chest pain and an elevated serum troponin level in the days following the COVID-19 mRNA vaccine. They usually are hemodynamically stable, and symptoms and cardiac biomarkers normalize within a few days[2] cardiac magnetic resonance studies, when performed early, frequently demonstrate abnormalities such as edema and late gadolinium enhancement (LGE), meeting Lake Louise Criteria for diagnosing myocarditis noninvasively [2],[3]
In classical myocarditis LGE can be predictive of a poor outcome [5]
Little is known about the prognostic value or expected evolution of these CMR abnormalities associated with post-COVID-19 mRNA vaccine myopericarditis. In this case series we report the evolution of CMR imaging compared with initial, acute phase, CMR in our cohort of patients with myopericarditis post COVID-19 mRNA vaccine.
Methods
This case review includes patients younger than 18 years of age presenting to Seattle Children’s Hospital with chest pain and elevated serum troponin level from April 1, 2021 to January 7, 2022 within one week of receiving the second dose of the Pfizer COVID-19 mRNA vaccine. Institutional Review Board approval was obtained. All patients were evaluated by a pediatric cardiologist, underwent ECG and echocardiogram, and were admitted for observation with telemetry, serial troponin measurements, and repeat cardiac testing as needed. All patients underwent CMR within 1 week of initial presentation and had repeat CMR imaging at 3-8 months follow up. CMR was performed on a 1.5 T Siemens scanner. CMR analysis was performed using CVI42 (version 5.11.4, Circle Cardiovascular Imaging Inc., Alberta Canada). Patients were excluded if they did not undergo CMR or did not have a follow up CMR. Initial and follow up CMR data for each patient were reviewed and compared using paired Student t-test. Statistical significance was defined as a p < 0.05. Statistical analysis was performed using SPSS 27 (SPSS Inc., Chicago, IL).
Results
A total of 35 patients with the diagnosis of myopericarditis associated with Pfizer COVID-19 mRNA vaccine are followed at our institution. Twelve patients were excluded as they never had CMR due to delayed presentation after initial symptoms resolved or admission to other centers. Six patients were excluded as they did not have a follow up CMR, either because they followed up out of state or a study is still pending. One patient was excluded as initial CMR was performed 3 weeks after presentation. Sixteen patients who had both acute phase and follow-up CMR available for review comprised the final cohort. This group had a median age of 15 years (range, 12-17), were mostly male (n=15, 94%), white and non-Hispanic (n= 14, 88%). One patient was Asian and one patient was American Indian. Median time to presentation from the second dose of the Pfizer COVID-19 mRNA vaccine was 3 days (range 2-4 days). All patients had chest pain. The most common other presenting symptoms were fever (n=6, 37.5%) and shortness of breath (n=6, 37.5%). All patients had elevated serum troponin levels (median 9.15 ng/mL, range 0.65-18.5, normal < 0.05 ng/mL). Twelve patients had c- reactive protein (CRP) measured with median value 3.45 mg/dL, range 0-6.5 mg/dL, normal < 0.08 mg/dL.
Ten (62.5%) patients had an abnormal electrocardiogram (ECG), with the most common finding being diffuse ST segment elevation. All patients had an echocardiogram on admission; 14/16 patients had normal left ventricular (LV) systolic function; two patients demonstrated mildly reduced LV systolic function with no dilation. Left ventricular ejection fraction (LVEF) for these two patients was 45% and 53% (normal > 55%). Median left LVEF was 59% (range 45-69%). No patients had pericardial effusion.
The initial CMRs were performed within 1 week of presentation (median 2, range 0-7 days). All were abnormal; all showed evidence of edema by T2 imaging and 15/16 had LGE in a patchy subepicardial to transmural pattern with predilection for the inferior LV free wall. Distribution of LGE can be seen in Figure 1. LV regional wall motion abnormalities were noted in 2 patients. CMR median LVEF% was 54%, range 46-63%. CMR LVEF was mildly decreased in 7 patients. CMR global longitudinal strain (GLS%) measurements were abnormal in 12 patients (median -16.1%, range -13.2% to -18.1%, normal <-18%).
Figure 1Distribution of Late Gadolinium Enhancement (LGE) in American Heart Association Myocardial Segments[12] Figure shows segment with number of patients and percent of cohort.
All patients were treated with nonsteroidal anti-inflammatory drugs (NSAIDs): 75% (n=12) received scheduled dosing (mostly, 10 mg/kg ibuprofen every 8 hours) with the remaining 4 receiving NSAIDs as needed for pain. The median time from vaccination to NSAID initiation was 2.5 days (range 0-4 days) and from symptom onset to NSAID initiation was 1 day (range 0-4 days). The two patients who presented with echocardiographic LV dysfunction were treated with intravenous immunoglobulin (IVIG) plus a corticosteroid per our institutional pathway for treatment of myocarditis [2]
One additional patient received IVIG without corticosteroids. Median hospital length of stay was 2 days (range 1-4 days) with no ICU admission and no significant morbidity or mortality. All patients had resolution of chest pain and down-trending serum troponin level prior to discharge.
All patients underwent follow up CMR at 3-8 months after their initial study (median 3.7 months, range 2.8-8.1 months). The results are compared in Table I. Follow up CMR LVEF (57.7 ±2.8%) was significantly improved from initial (54.5 ± 5.5%, p < 0.05), and none of the patients had regional wall motion abnormalities. LVEF by echocardiogram was normal for all patients at the time of follow up. Eleven patients (68.8%) had persistent LGE, although there was a significant decrease in the quantifiable LGE% (8.16± 5.74%) from the initial study (13.77± 8.53%, p <0.05). Cardiac edema resolved in all but one patient. GLS% remained abnormal in most patients (75%, mean -16.4 ± 2.1%) at follow up without significant change from the initial study (-16.0 ± 1.7, p = 0.6). Examples of initial and follow up CMR images are shown in Figure 2. The patient who received IVIG alone and one patient who received IVIG plus corticosteroid had resolution of LGE, and the other had persistence of LGE.
Table 1Covid Vaccine-Associated Myopericarditis Findings in 16 patients
Initial (Mean±SD)
Follow up (Mean±SD)
P value
Echocardiographic LVEF %
59.4±6.0
62.6±2.8
<0.05
Electrocardiogram
Abnormal
Normal
10 (62.5%)
6 (37.5%)
Peak Serum Troponin (ng/mL)
9.0± 5.2
CMR LVEF %
54.5 ± 5.5
57.7 ±2.7
<0.05
CMR LGE % (n=15*)
13.5± 8.3
7.7 ± 5.7
<0.001
CMR global longitudinal strain % (n=15*)
-16.0 ± 1.7
-16.4 ± 2.1
0.5
*Initial source images were not available for reanalysis for one patient.
Figure 2CMR images from 3 days after admission of a 16-year-old male who presented to emergency room with chest pain and elevated troponin 3 days after receiving Pfizer COVID-19 mRNA vaccine. Initial CMR. 1a and 1b. subepicardial to midmyocardial LGE in inferior and inferolateral LV wall from base to apex (arrows). 1c shows T2 hyper-intensity in similar segments, consistent with edema. 1d, 1e and 1f. Follow up CMR 4.4 months later. LGE still persistent but decreased from 26% to 19.84% (arrows), LVEF remained stable at 58%. There is improved T2 hyperintensity.
Eight patients (5 of whom had persistent LGE) underwent 24-hour cardiac rhythm monitoring, all of which studies were normal. Six patients, all with persistent LGE, underwent exercise tests, all of which were normal. Four patients complained of intermittent chest pain at follow up with no identifiable abnormality on evaluation; no therapy or intervention was required. No patient received heart failure medication.
DISCUSSION
[3]We previously reported 15 patients with clinically suspected SARS-CoV-2 mRNA vaccine induced myopericarditis. All patients had an abnormal CMR, with edema and or LGE in addition to clinical symptoms and troponin elevation, and some had abnormal ECG or echocardiogram
We have since established a clinical protocol for serial CMR performance in these patients consistent with the 2021 American Heart Association (AHA) statement that stressed the risk of sudden cardiac death, particularly with exercise, while active inflammation is present. [6]
our patients were restricted from exercise on discharge. Repeat CMR was performed within 3-6 months to guide next clinical decision-making steps; timing was modified in some individuals based on scanner accessibility and safety precautions during the COVID-19 pandemic. Although symptoms were transient and most patients appeared to respond to treatment (soley with NSAIDS), we demonstrated persistence of abnormal findings on CMR at follow up in most patients, albeit with improvement in extent of LGE.
CMR has increasingly been identified as an important diagnostic tool for myocarditis given its ability to identify subclinical injury and fibrosis by markers of LGE and edema. CMR also has been utilized in longitudinal follow up of patients with myocarditis to help therapeutic management, although exact screening protocols remain controversial[6]
The presence of LGE is an indicator of cardiac injury and fibrosis and has been strongly associated with worse prognosis in patients with classical acute myocarditis. In a meta-analysis including 8 studies, Yang et al found that presence of LGE is a predictor of all cause death, cardiovascular death, cardiac transplant, rehospitalization, recurrent acute myocarditis and requirement for mechanical circulatory support[5]]Similarly, Georgiopoulos et al found presence and extent of LGE to be a significant predictor of adverse cardiac outcomes in an 11 study meta-analysis[7]
The persistence of LGE over time and its prognostic value is less well established. Malek et al found that in a cohort of 18 patients with myocarditis, nearly 70% had persistent CMR changes at a median follow-up time of 7 months[5],[9] Dubey et al found similar findings in their cohort of 12 pediatric patients, with persistence of LGE in all patients despite resolution of edema.
Prognostic meaning of LGE in vaccine associated myopericarditis requires further study.
Strain analysis by CMR also has been shown to have prognostic utility in myocarditis even in the setting of normal LV function[10]Strain testing can be performed without use of contrast material and can be particularly useful in situations where contrast administration is challenging or contraindicated. Notably, in our cohort, though there was significant reduction in LGE at follow up, abnormal strain persisted for the majority of patients at follow up.
This study has certain limitations. Patients who did not seek medical attention during acute illness or did not present with significant symptoms and require hospitalization were not captured, and their disease course may be different. Incomplete CMR data on other patients precludes extrapolation of our CMR findings to all who experienced mRNA vaccine-related myopericarditis. In addition, follow-up CMR timeframes varied from patient to patient making it difficult to predict the timing of CMR changes over time. the total number of patients reported is small, limiting ability to draw conclusions about the effect of treatment modalities or to generalize regarding outcomes of vaccine-associated myopericarditis.
In a cohort of adolescents with COVID-19 mRNA vaccine-related myopericarditis, a large portion have persistent LGE abnormalities, raising concerns for potential longer-term effects. Despite these persistent abnormalities, all patients had rapid clinical improvement and normalization of echocardiographic measures of systolic function. For patients with short acute illness, no dysfunction demonstrated by echocardiogram at presentation and resolution of symptoms at follow up, return to sports was guided by normalization of CMR alone. In patients with persistent CMR abnormalities we performed exercise stress testing prior to sports clearance per myocarditis recommendations[6] We plan to repeat CMR at 1 year post-vaccine for our cohort to assess for resolution or continued CMR changes.
The CDC notes that even though the absolute risk for myopericarditis following mRNA COVID-19 vaccine is small, the relative risk is higher for particular groups, including males 12-39 years of age.
Some studies have suggested that increasing the interval between the first and second dose may reduce the incidence of myopericarditis in this population [11]
These data led to an extension in CDC recommended dosing interval between dose 1 and dose 2 to 8 weeks. Further follow up assessment and larger multicenter studies are needed to determine the ultimate clinical significance of persistent CMR abnormalities in patients with post COVID-19 vaccine myopericarditis
Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al. Morbidity and Mortality Weekly Report Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices-United States, June 2021 2021;70. https://doi.org/10.1161/CIR.0000000000000239?url_.
mRNA Coronavirus-19 Vaccine–Associated Myopericarditis in Adolescents: A Survey Study.
Diagnostic and Prognostic Value of Cardiac Magnetic Resonance Strain in Suspected Myocarditis With Preserved LV-EF: A Comparison Between Patients With Negative and Positive Late Gadolinium Enhancement Findings.
We describe the evolution of Cardiac MRI (CMR) findings in 16 patients, 12-17 years of age, with myopericarditis after the second dose of the Pfizer mRNA COVID-19 vaccine. Although all patients showed rapid clinical improvement, many had persistent CMR findings at 3-8 month follow up.
Figures
[12]Figure 1Distribution of Late Gadolinium Enhancement (LGE) in American Heart Association Myocardial Segments
. Figure shows segment with number of patients and percent of cohort.
Another item can be added to the list of those who have concerns about the integrity of the 2020 general election in Arizona.
President Joe Biden won the state by 10,457 votes (0.3 percent of the 3.4 million cast), which was the narrowest margin of any of the swing states that went for him.
Further, it was only the second time in the previous 70 years the state has sided with the Democratic candidate for president.
Last week, Arizona Gov. Doug Ducey signed House Bill 2492 into law, which requires those who are only eligible to vote in federal elections in Arizona to provide documentary proof of citizenship.
“If they do not, they will not be eligible to vote in a presidential election or by mail,” Ducey’s office said in a Wednesday news release. “In 2020, more than 11,600 Federal Only Voters in Arizona participated in the general election without providing proof of citizenship. In Maricopa County alone, there are currently 13,042 active registered voters who have not provided evidence of citizenship to vote through use of the federal form.”
In other words, more people voted without being required to provide proof of citizenship — 11,600 — than the margin of Biden’s win in the Grand Canyon State — 10,457 votes.
In February, state GOP Rep. Jake Hoffman told Courthouse News that HB 2492 was intended to address a concerning trend in the number of “federal only” voters.
“In 2018, there were only 1,700 individuals who didn’t have documentary proof of citizenship on file,” Hoffman said. “In 2020, there were almost 12,000. So clearly, this is a trend that is increasing. This bill ensures that there is maximum flexibility to provide documentary proof of citizenship, but we don’t want foreign interference in our elections.”
And many of those federal-only votes likely came from Maricopa County, which encompasses the Phoenix metropolitan area and accounts for over 60 percent of the voters in the state.
In 2020, it was the only county in the state to flip from red to blue. Biden carried it with about the same 45,000-vote margin Republican Donald Trump did in 2016.
In a letter explaining his support for HB 2492, Ducey said, “Election integrity means counting every lawful vote and prohibiting any attempt to illegally cast a vote.”
This bill “is a balanced approach that honors Arizona’s history of making voting accessible without sacrificing security in our elections,” he added. “Federal law prohibits non-citizens from voting in federal elections. Arizona law prohibits non-citizens from voting for all state and local offices, and requires proof of citizenship.”
Democratic state Sen. Sally Ann Gonzales said the law creates a barrier to vote.
“I think [Republicans] hope is that not everybody is going to jump through those hoops and their hope is that the groups that are going to be impacted more are going to be the groups that are likely to vote against them,” Quezada told Governing.
In 2013, the U.S. Supreme Court ruled 7-2 that Arizona could not require proof of citizenship beyond an oath for those seeking to vote in federal elections. However, the state could continue to have ID requirements to register to vote for state and local elections. The Court held that Arizona’s law at the time was pre-empted by the National Voter Registration Act of 1993.
Federal law “precludes Arizona from requiring a Federal Form applicant to submit information beyond that required by the form itself,” then-Justice Antonin Scalia wrote for the majority.
“Arizona may, however, request anew that the [Election Assistance Commission] include such a requirement among the Federal Form’s state-specific instructions, and may seek judicial review of the EAC’s decision under the Administrative Procedure Act,” he added.
The Associated Press reported that two lawsuits had already been filed challenging HB 2492, including one by Democratic election attorney Marc Elias on behalf of Mi Famila Vota.
Elias played a very active role during the 2020 campaign season suing in multiple battleground states to get election procedures changed.
Last month, the Election Systems Integrity Institute released a report concluding that the Maricopa County mail-in ballot signature verification process used during the 2020 general election was deeply flawed.
The study, overseen by systems engineer Shiva Ayyadurai, found that the county allowed approximately 200,000 ballot envelopes with mismatched signatures to be forwarded for counting without adequate additional review.
ESII researchers reported that 11.3 percent of the approximately 1.9 million mail-in ballots should have gone through the curing process, rather than the 1.31 percent — or about 25,000 — that actually did.
Ultimately, only 587 ballots were rejected, or 0.03 percent.
It should be noted that no information has been disclosed regarding whom any of these ballots was cast for. Therefore, even if all 200,000 ballots in question were to be thrown out — a highly unlikely proposition — there is no way to know whether the outcome of the Arizona election would be changed.
Based on the findings of the study, the Arizona Attorney General’s Office sent a letter to the Maricopa County recorder and the Maricopa County Board of Supervisors requesting the voter signature files.
Why not have a age limit for a sex change?
Photo My security sign
Visits: 29
So think about it. We have laws that stop people from doing things before adulthood. Drinking, Smoking, Voting, serving in the Military, etc. Why not make it illegal for a child to have a sex change operation till they reach adulthood? 18-21. Even then they’re still very immature.
You have Progressives who have no problem with teaching 5-8 year olds about transgender and being gay. I just wonder if their parents taught them about that. Odds are no, So why force something like this on children?
Also is it something the government should pay for? Is this something that schools should be teaching? I can see it now. Class instead of learning how to read and write, we will discuss why you should or should not have a penis or vagina.
Our border patrols heroes were cleared of charges that they whipped Haitians trying to come here illegally to vote, or take American jobs.
Now that the agents have reportedly been cleared of any wrongdoing, Congressman Gonzales ( his district ) blasted the administration for sweeping the investigation under the rug. But they’re not out of the woods yet. They made asses out of Biden and his stooges.
If OPR finds that the agents violated CBP policy, they could face termination.
164
